Critical shortage of plasma supply creates life-threatening treatment delays for patients

Hospitals and blood banks face severe plasma shortages that delay critical treatments for patients with bleeding disorders, liver disease, and trauma injuries. The US supplies most global plasma, but geopolitical tensions and supply chain disruptions create unpredictable shortages that force medical facilities to ration life-saving treatments. Current inventory management and procurement systems fail to provide real-time visibility into available plasma stocks across regions.